Definite diagnosis of perilymphatic fistula (PLF) by biochemical diagnostic marker CTP (cochlin-tomo protein)
Not Applicable
- Conditions
- perilymphatic fistula (PLF)
- Registration Number
- JPRN-UMIN000012698
- Lead Sponsor
- Saitama Medical University Faculty of Medicine, Otorhinolaryngology,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
(1) acoustic neurinoma or other CNS disorder causing hearing loss by MRI scan, (2) viral labyrinthitis by clinical symptoms and increase of antibody titer, (3) sensorineural hearing loss occurring after administration of aminoglycosides, loop diuretics or platinum-based drugs, (4) severe systemic illness with a short life expectancy such as malignant tumors, (5) pregnancy or lactation, (6) diagnosis as inappropriate for the trial.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Detection of CTP and concentration. Auditory and vestibular test results, symptoms of the cases.
- Secondary Outcome Measures
Name Time Method